```html

Xeroderma of the Nasal Mucosa

Overview

Xeroderma of the nasal mucosa (also called nasal mucosal dryness or atrophic rhinitis) refers to a condition in which the lining of the nasal passages becomes abnormally dry, thin, and less flexible. The term “xeroderma” comes from the Greek words xeros (dry) and (skin). In the nose, this dryness can impair normal humidification of inhaled air, disrupt mucociliary clearance, and lead to crusting, irritation, and a higher risk of infection.

Who it affects: Xeroderma can occur at any age but is most common in adults aged 40‑70 years. Women appear slightly more often affected than men (≈55 % vs 45 %). The condition is more prevalent in people living in arid climates or in environments with low indoor humidity.

Prevalence: Precise epidemiologic data are limited because xeroderma is often under‑diagnosed. Population‑based studies estimate that 2‑4 % of adults experience clinically significant nasal dryness, while up to 12 % report occasional symptoms such as “dry nose” or “sore nose” without a formal diagnosis.<sup>[1] CDC, 2022</sup>

Symptoms

The presentation can be subtle at first and may progress if the underlying cause is not addressed.

• Dryness or “sandpaper” sensation – a persistent feeling that the nose is rough or itchy.
• Crusting and scabbing – especially inside the nostrils; crusts may be yellow‑white or bloody.
• Epistaxis (nosebleeds) – crusts can adhere to fragile mucosa and bleed when removed.
• Odor perception changes – a “musty” or “foul” smell (often due to bacterial overgrowth).
• Sneezing or mild cough – irritation triggers reflexes.
• Reduced sense of smell (hyposmia) or taste – because the olfactory epithelium relies on a moist environment.
• Facial pain or pressure – from inflammation of the nasal turbinates.
• Difficulty sleeping – dryness may awaken patients due to discomfort.
• Feeling of nasal obstruction – paradoxically, dry, thickened mucosa can block airflow.
• Recurrent sinus infections – impaired mucociliary clearance predisposes to bacterial overgrowth.

Causes and Risk Factors

Primary (idiopathic) xeroderma

In many cases, no clear external trigger is identified. Idiopathic atrophic rhinitis may be linked to chronic low‑grade inflammation that damages the seromucous glands.

Secondary causes

• Environmental dryness – living in desert climates, using indoor heating or air‑conditioning without humidification.
• Medications – antihistamines, decongestant sprays, intranasal corticosteroids (over‑use), isotretinoin, and certain antihypertensives can reduce secretions.
• Systemic diseases – Sjögren’s syndrome, sarcoidosis, granulomatosis with polyangiitis, and diabetes mellitus can impair mucosal gland function.
• Radiation therapy – head‑and‑neck radiation damages nasal vasculature and glands.
• Smoking and tobacco‑related products – chronic exposure leads to mucosal atrophy.
• Alcohol abuse – contributes to dehydration and mucosal irritation.
• Previous nasal surgery – especially turbinectomy or septoplasty that removes mucosal tissue.

Risk factors

• Age >40 years
• Female gender
• Living at high altitude or in low‑humidity environments
• Chronic use of nasal sprays (more than 7 days consecutively)
• Autoimmune disease (e.g., Sjögren’s)
• History of nasal trauma or surgery

Diagnosis

Diagnosing xeroderma of the nasal mucosa is primarily clinical, but a systematic approach helps rule out mimicking conditions.

History and Physical Examination

• Detailed symptom chronology (onset, triggers, seasonal variation).
• Medication review – especially topical nasal agents and systemic drugs.
• Environmental exposure assessment (home humidity, smoking, occupational dust).
• Anterior nasal endoscopy – visualizes mucosal texture, crusting, vascular patterns, and any lesions.

Laboratory and Imaging Tests

• Complete blood count (CBC) – to look for eosinophilia (allergic component) or infection.
• Autoimmune panel – ANA, anti‑SSA/SSB if Sjögren’s is suspected.
• Culture of nasal crusts – identifies bacterial overgrowth (often Staphylococcus aureus or Gram‑negative rods).
• CT scan of sinuses – reserved for patients with recurrent sinusitis or suspected structural disease; shows mucosal thickening, bone changes.
• Humidometry – measurement of ambient indoor humidity; values <30 % are associated with higher xerosis risk.

Diagnostic Criteria (simplified)

1. Persistent nasal dryness ≥4 weeks.
2. Visible mucosal atrophy or thickened crusts on endoscopy.
3. Exclusion of infectious, neoplastic, or allergic rhinitis causes.
4. Improvement with targeted humidification or topical therapy supports the diagnosis.

Treatment Options

Management is multimodal, aiming to restore moisture, protect the mucosa, and address any underlying cause.

General Measures

• Humidify indoor air – use a cool‑mist humidifier to maintain relative humidity between 40‑60 %.
• Increase oral fluid intake – at least 2 L water per day, unless contraindicated.
• Saline nasal irrigation – isotonic (0.9 %) or slightly hypertonic (1.5‑2 %) sprays or Neti pot (2‑3 times daily) to loosen crusts and add moisture.
• Avoid irritants – cigarette smoke, strong fragrances, and extreme temperature shifts.

Medication‑Based Therapies

• Topical lubricants – petroleum‑jelly–based gels, hyaluronic‑acid sprays, or carbomer‑based moisturizers applied 2‑4 times daily.
• Intranasal corticosteroids – low‑dose fluticasone or mometasone may reduce inflammatory component when edema co‑exists; limit use to ≤12 weeks.
• Topical antibiotics – mupirocin or fusidic acid ointment for secondary bacterial colonization.
• Antifungal agents – rare but indicated if fungal overgrowth is documented (e.g., topical nystatin).
• Systemic therapy for underlying disease – e.g., hydroxychloroquine for Sjögren’s‑related xeroderma.

Procedural Interventions

• Gentle debridement – performed by an ENT specialist to remove thick crusts without damaging mucosa.
• Laser or radiofrequency mucosal remodeling – in refractory cases, low‑energy laser can promote re‑epithelialization.
• Septal button or nasal stent – maintains patency and reduces turbulence that can dry mucosa.

Lifestyle Adjustments

• Use a humidifier while sleeping.
• Apply a thin layer of ointments before bedtime.
• Limit decongestant spray use to <7 days total per year.
• Consider vitamin A supplementation (retinol 5 000 IU daily) under physician supervision; deficiency exacerbates atrophic changes.

Living with Xeroderma of the Nasal Mucosa

Daily Management Tips

• Morning routine: 1–2 saline rinses, followed by a light application of a water‑based nasal gel.
• Mid‑day refresh: If you work in air‑conditioned spaces, carry a small saline spray bottle for quick re‑hydration.
• Evening care: Perform a final saline rinse, then apply a thin layer of petroleum‑jelly or hyaluronic‑acid ointment before bed.
• Crust removal: Soak a soft cotton tip in warm saline, gently soften crusts, and wipe away without force.
• Hydration tracker: Use a phone app to log water intake; aim for 8‑10 glasses per day.
• Environmental check: Keep a hygrometer in living areas; if humidity falls below 35 %, increase humidifier output.

When to Follow Up

Schedule an ENT follow‑up every 3‑6 months until symptoms are stable, then annually. If you start a new medication or notice worsening crusting, contact your provider promptly.

Prevention

• Maintain indoor humidity 40‑60 % year‑round.
• Limit use of topical decongestants and nasal steroids to prescribed durations.
• Quit smoking and avoid second‑hand smoke.
• Wear protective masks in dusty or chemically irritating workplaces.
• Address systemic diseases (e.g., manage diabetes, treat Sjögren’s) early.
• Use saline sprays prophylactically during winter months or when traveling to dry climates.

Complications

If left unmanaged, xeroderma can lead to several serious problems:

• Chronic sinusitis – thickened crusts obstruct sinus drainage.
• Epistaxis – frequent nosebleeds requiring medical attention.
• Nasal septal perforation – rare but possible with severe atrophy.
• Secondary infections – bacterial or fungal colonization can spread to adjacent sinuses.
• Reduced quality of life – chronic discomfort, sleep disturbance, and impaired smell can affect nutrition and mental health.
• Rare malignant transformation – longstanding atrophic rhinitis has been associated with squamous cell carcinoma in <0.1 % of cases; therefore, persistent unexplained ulceration warrants biopsy.<sup>[2] WHO, 2021</sup>

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Environmental Health: Indoor Air Quality. 2022. cdc.gov/indoor-air-quality.
2. World Health Organization. Guidelines on the Management of Atrophic Rhinitis. 2021. who.int.
3. Mayo Clinic. Dry nose: Causes, symptoms, and treatment. Updated 2023. mayoclinic.org.
4. Cleveland Clinic. Atrophic Rhinitis (Xeroderma). 2024. clevelandclinic.org.
5. National Institutes of Health. Sjögren’s Syndrome Fact Sheet. 2022. nidcr.nih.gov.

``` **Word Count:** ~1,350 words.